COVID-19 mRNA vaccine (BNT162) Date of Revision of the Text - Form to be diluted 30 µg/dose for adults and ≥12 years (purple cap)

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

May 2022

Detailed information on this medicinal product is available on the website of the European Medicines Agency